Role of vitamin B12 and folic acid in treatment of Alzheimer’s disease: a meta-analysis of randomized control trials
Figure 3.Effect of vitamin B12 and folic acid on change in ADAS-Cog score. In both the pooled treatment and control groups, there was non-significant change in ADAS-Cog score after 6-months treatment (SMD = 0.06, 95% CI = −0.22 to 0.33, p = 0.68).